ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Androgen Society 3rd Annual Meeting Review (Day 2)
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 201650" data-attributes="member: 13851"><p><h2>Androgen Society 3rd Annual Meeting Review (Day 2) – Summary:</h2><p><strong><em>Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, reviews the second day of the 3rd annual meeting of the Androgen Society, an international organization consisting of healthcare professionals interested in testosterone deficiency and its treatment. </em></strong><em>The day began with presentations on testosterone therapy and type 2 diabetes by Gary Wittert, MD, Hugh Jones, MD, and Farid Saad, MD. These presenters suggested that testosterone <a href="https://pubmed.ncbi.nlm.nih.gov/32558149/" target="_blank">could lead to remission of diabetes mellitus</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/33338415/" target="_blank">potentially prevent diabetes</a>, and improve glycemic control. They were followed by a presentation on testosterone, anemia, and hematocrit by Sudarshan Ramachandran, Ph.D., one on COVID-19 and testosterone by Mary Samplaski, MD, and a panel discussion on testosterone’s impact on prostate cancer. Mohit Khera, MD, presented the possibility of testosterone therapy performing a protective and/or therapeutic role against prostate cancer. Sharon Parish, MD, and Leah Millheiser, MD, presented testosterone therapy for women and how it benefits sexual function. The day concluded with a presentation by Daniel Kelly, MD, on the complex, context-dependent relationship between testosterone and atherosclerosis.</em></p><p><em></em></p><p><em>A summary of day one of the meeting can be watched <strong><a href="https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-1/" target="_blank">here</a></strong>. A summary of the third day of this conference will be posted next week on <strong>GRU</strong>. For more on ADT, visit our <strong><a href="https://grandroundsinurology.com/next-generation-androgen-deprivation-therapy/" target="_blank">Next Generation Androgen Deprivation Therapy Learning Center</a></strong>.</em></p><p></p><p></p><p>[URL unfurl="true"]https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-2/[/URL]</p><p></p><p></p><p>[ATTACH=full]14421[/ATTACH]</p><p>[ATTACH=full]14422[/ATTACH]</p><p>[ATTACH=full]14423[/ATTACH]</p></blockquote><p></p>
[QUOTE="madman, post: 201650, member: 13851"] [HEADING=1]Androgen Society 3rd Annual Meeting Review (Day 2) – Summary:[/HEADING] [B][I]Abraham Morgentaler, MD, FACS, Associate Clinical Professor of Urologic Surgery at Harvard University, reviews the second day of the 3rd annual meeting of the Androgen Society, an international organization consisting of healthcare professionals interested in testosterone deficiency and its treatment. [/I][/B][I]The day began with presentations on testosterone therapy and type 2 diabetes by Gary Wittert, MD, Hugh Jones, MD, and Farid Saad, MD. These presenters suggested that testosterone [URL='https://pubmed.ncbi.nlm.nih.gov/32558149/']could lead to remission of diabetes mellitus[/URL], [URL='https://pubmed.ncbi.nlm.nih.gov/33338415/']potentially prevent diabetes[/URL], and improve glycemic control. They were followed by a presentation on testosterone, anemia, and hematocrit by Sudarshan Ramachandran, Ph.D., one on COVID-19 and testosterone by Mary Samplaski, MD, and a panel discussion on testosterone’s impact on prostate cancer. Mohit Khera, MD, presented the possibility of testosterone therapy performing a protective and/or therapeutic role against prostate cancer. Sharon Parish, MD, and Leah Millheiser, MD, presented testosterone therapy for women and how it benefits sexual function. The day concluded with a presentation by Daniel Kelly, MD, on the complex, context-dependent relationship between testosterone and atherosclerosis. A summary of day one of the meeting can be watched [B][URL='https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-1/']here[/URL][/B]. A summary of the third day of this conference will be posted next week on [B]GRU[/B]. For more on ADT, visit our [B][URL='https://grandroundsinurology.com/next-generation-androgen-deprivation-therapy/']Next Generation Androgen Deprivation Therapy Learning Center[/URL][/B].[/I] [URL unfurl="true"]https://grandroundsinurology.com/androgen-society-3rd-annual-meeting-review-day-2/[/URL] [ATTACH type="full" alt="Screenshot (4826).png"]14421[/ATTACH] [ATTACH type="full" alt="Screenshot (4827).png"]14422[/ATTACH] [ATTACH type="full" alt="Screenshot (4828).png"]14423[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
Androgen Society 3rd Annual Meeting Review (Day 2)
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top